Wave Life Sciences, Inc. (WVE)

NASDAQ: WVE · Real-Time Price · USD

3.590

-0.040 (-1.10%)

At close: Oct 30, 2026, 4:00 PM EDT

3.630

+0.040 (1.11%)

After-hours: Oct 30, 2026, 7:51 PM EDT

Wave Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	70.92	42.73	108.3	113.31	3.65	40.96
Revenue Growth	-35.07%	-60.55%	-4.42%	3005.10%	-91.09%	104.03%
Cost of Revenue	205.39	182.78	159.68	130.01	115.86	121.88
Gross Profit	-134.47	-140.05	-51.38	-16.7	-112.21	-80.91
Selling, General & Admin	93.14	75.33	59.02	51.29	50.51	46.11
Operating Expenses	93.14	75.33	59.02	51.29	50.51	46.11
Operating Income	-227.61	-215.38	-110.4	-68	-162.72	-127.02
Interest & Investment Income	17.45	10.48	10.16	7.93	1.57	0.03
Other Non Operating Income (Expenses)	-0.37	0.53	3.23	1.88	0.01	4.54
Pretax Income	-210.53	-204.38	-97.01	-58.19	-161.14	-122.45
Income Tax Expense	-	-	-	-0.68	0.68	-0.2
Net Income	-210.53	-204.38	-97.01	-57.51	-161.82	-122.25
Net Income to Common	-210.53	-204.38	-97.01	-57.51	-161.82	-122.25
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	197	169	138	106	79	52
Shares Outstanding (Diluted)	197	169	138	106	79	52
Shares Change	20.23%	21.96%	30.33%	34.55%	52.16%	32.12%
EPS (Basic)	-1.07	-1.21	-0.70	-0.54	-2.05	-2.36
EPS (Diluted)	-1.07	-1.21	-0.70	-0.54	-2.05	-2.36
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-208.39	-188.21	-151.96	-20.55	-129.14	-89.55
Free Cash Flow Per Share	-1.06	-1.12	-1.10	-0.19	-1.64	-1.73
Gross Margin	-189.60%	-	-47.44%	-14.74%	-	-197.52%
Operating Margin	-320.94%	-504.09%	-101.94%	-60.01%	-4459.30%	-310.07%
Profit Margin	-296.86%	-478.34%	-89.57%	-50.76%	-4434.72%	-298.42%
Free Cash Flow Margin	-293.83%	-440.50%	-140.31%	-18.13%	-3539.11%	-218.61%
EBITDA	-224.19	-211.94	-106.51	-63	-156.15	-119.53
EBITDA Margin	-	-	-98.34%	-55.60%	-	-291.80%
D&A For EBITDA	3.42	3.44	3.9	5	6.57	7.48
EBIT	-227.61	-215.38	-110.4	-68	-162.72	-127.02
EBIT Margin	-	-	-101.94%	-60.01%	-	-

SEC Filings: 10-K · 10-Q